Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
personalized medicine
Biotech
ARPA-H unveils programs to develop custom gene editing therapies
Together, the two programs represent a nine-figure investment from the HHS, Secretary Robert F. Kennedy Jr., said.
Darren Incorvaia
Sep 26, 2025 10:41am
Genentech scraps $2B cell therapy pact with Adaptive
Aug 18, 2025 2:40pm
Center launches with $20M to create CRISPR therapies for kids
Jul 8, 2025 11:59am
Top health agency awards $54M for tumor treatment, research
Aug 27, 2024 4:00am
Illumina, Henry Ford to explore DNA testing for heart disease
Apr 17, 2023 9:50am
GSK pays Tempus $70M to expand access to patient data library
Oct 18, 2022 8:05am
